Aggressive surgical resection for cholangiocarcinoma.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMID 7534059)

Published in Arch Surg on March 01, 1995

Authors

W K Washburn1, W D Lewis, R L Jenkins

Author Affiliations

1: Division of Hepatobiliary Surgery and Liver Transplantation, New England Deaconess Hospital, Boston, Mass.

Articles citing this

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42

Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg (1998) 2.60

Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54

Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36

Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24

Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17

Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma. J Gastrointest Surg (2015) 2.03

Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99

Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg (2000) 1.71

Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology (2012) 1.70

Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) (2011) 1.54

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study. Gut Liver (2009) 1.43

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg (2004) 1.35

Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg (1998) 1.32

Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg (2012) 1.23

Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg (2007) 0.96

Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology (2012) 0.93

The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma. J Exp Clin Cancer Res (2010) 0.92

Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma. Dig Dis Sci (2000) 0.92

Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol (2009) 0.91

The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford) (2005) 0.88

Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87

Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today (2011) 0.86

Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut (1999) 0.85

Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol (2013) 0.83

The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol (2015) 0.80

Colonic metastasis of Klatskin tumor: case report and discussion of the current literature. World J Gastroenterol (2006) 0.80

Matrigel induces L-plastin expression and promotes L-plastin-dependent invasion in human cholangiocarcinoma cells. Oncol Lett (2014) 0.76

Surgical palliation for unresectable hilar cholangiocarcinoma. HPB (Oxford) (2005) 0.75

Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy. World J Gastrointest Endosc (2015) 0.75

Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma. Surg Today (2011) 0.75

R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci (2008) 0.75

Articles by these authors

Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer (1996) 2.26

Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10

Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med (1994) 1.63

Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49

Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl (2001) 1.46

Surgical management of nonparasitic cystic liver disease. Am J Surg (1991) 1.45

Surgical treatment of biliary cystadenoma. A report of 15 cases. Arch Surg (1988) 1.43

Resting energy expenditure in patients with end-stage liver disease and in normal population. JPEN J Parenter Enteral Nutr (1987) 1.38

Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology (1988) 1.32

The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology (1997) 1.29

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27

Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood (1988) 1.22

The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg (1992) 1.22

Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg (1999) 1.15

Live donor adult liver transplantation using right lobe grafts: donor evaluation and surgical outcome. Arch Surg (2001) 1.13

Liver transplantation for primary hepatic cancer. Transplantation (1992) 1.13

Psychiatric syndromes in children and their relation to family background. Am J Orthopsychiatry (1966) 1.08

Life-threatening hypophosphatemia after right hepatic lobectomy for live donor adult liver transplantation. Liver Transpl (2001) 1.08

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation (1987) 1.07

Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg (1990) 1.06

Steatosis in donor and transplant liver biopsies. Hum Pathol (2000) 1.06

The direct-injection GLC analysis of xylenols in industrial wastewaters. Bull Environ Contam Toxicol (1977) 1.06

Improved survival after live donor adult liver transplantation (LDALT) using right lobe grafts: program experience and lessons learned. Am J Transplant (2006) 1.06

Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis (1994) 1.05

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplant Proc (1987) 1.03

Retroversus implantation of a liver graft: a novel approach to the deceased donor with situs inversus totalis. Am J Transplant (2007) 1.03

Role of staging laparoscopy in the treatment of hepatic malignancy. Am J Surg (1994) 1.01

Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation (1988) 1.01

Hepatic retransplantation in New England--a regional experience and survival model. Transplantation (1993) 1.01

A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer (1998) 1.00

Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch Surg (1987) 0.98

The acquired immunodeficiency syndrome and transplantation. Transplantation (1987) 0.95

Liver masses: replacement of conventional T2-weighted spin-echo MR imaging with breath-hold MR imaging. Radiology (1996) 0.95

Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg (1996) 0.94

Biliary tract complications after liver transplantation. Arch Surg (1995) 0.93

Liver transplantation for autoimmune hepatitis: a long-term pathologic study. Hepatology (2000) 0.92

Herbal toxicity and fatal hepatic failure. Am J Med (1999) 0.92

Graft function and outcome of older (> or = 60 years) donor livers. Transplantation (1996) 0.92

Distal splenorenal shunt: role, indications, and utility in the era of liver transplantation. Arch Surg (1999) 0.91

Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography. AJR Am J Roentgenol (1993) 0.91

Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg (1998) 0.90

Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation (1998) 0.90

Gilles de la Tourette's syndrome in identical twins. Arch Neurol (1983) 0.90

Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation (1995) 0.90

Surgical aspects of sclerosing cholangitis. Results in 178 patients. Ann Surg (1990) 0.88

Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy (1992) 0.88

Recovery of visual-spatial learning and memory in chronic alcoholics. J Clin Psychol (1981) 0.86

Recurrent hepatitis B, hepatitis C, and combined hepatitis B and C in liver allografts: a comparative pathological study. Hum Pathol (2000) 0.86

Survival from hepatic transplantation. Relationship of protein synthesis to histological abnormalities in patient selection and postoperative management. Ann Surg (1986) 0.86

Liver transplantation: MR angiography with surgical validation. Radiology (1991) 0.86

A comparison of operation, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography in biliary complications after hepatic transplantation. J Am Coll Surg (1994) 0.85

Treatment of giant hemangiomas of the liver by enucleation. J Am Coll Surg (1994) 0.85

Primary malignant melanoma of the biliary tract. Liver Transpl Surg (1995) 0.85

Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology (1996) 0.85

Nutrition in patients undergoing orthotopic liver transplant. JPEN J Parenter Enteral Nutr (1986) 0.85

The Boston Center for Liver Transplantation (BCLT). Initial experience of a new surgical consortium. Arch Surg (1986) 0.84

Liver transplantation for adult polycystic liver disease. Liver Transpl Surg (1996) 0.84

Transfer of congenital factor XI deficiency from a donor to a recipient by liver transplantation. N Engl J Med (1987) 0.84

L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg (1997) 0.84

Nifedipine interaction with tacrolimus in liver transplant recipients. Ann Pharmacother (1997) 0.84

Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Gastroenterology (1987) 0.83

Liver transplantation. Surg Clin North Am (1985) 0.83

Juvenile delinquents revisited. Adult criminal activity. Arch Gen Psychiatry (1980) 0.83

Whole body leucine, phenylalanine, and tyrosine kinetics in end-stage liver disease before and after hepatic transplantation. Metabolism (1987) 0.83

The runaway reaction. Am J Psychiatry (1971) 0.82

The runaway reaction. A case study. J Am Acad Child Psychiatry (1972) 0.82

Biliary intervention by means of percutaneous puncture of the antecolic jejunal loop. Radiology (1995) 0.82

Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol (1999) 0.82